CLEVELAND BIOLABS INC's ticker is CBLI and the CUSIP is 185860202. A total of 19 filers reported holding CLEVELAND BIOLABS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $0 | – | 51 | 0.0% | 0.00% | – |
| Q1 2021 | $0 | – | 51 | +50.0% | 0.00% | – |
| Q4 2020 | $0 | – | 34 | 0.0% | 0.00% | – |
| Q3 2020 | $0 | -100.0% | 34 | -92.6% | 0.00% | – |
| Q2 2020 | $1,000 | – | 457 | +1328.1% | 0.00% | – |
| Q1 2020 | $0 | – | 32 | -73.6% | 0.00% | – |
| Q3 2019 | $0 | – | 121 | 0.0% | 0.00% | – |
| Q2 2019 | $0 | – | 121 | +163.0% | 0.00% | – |
| Q1 2019 | $0 | – | 46 | -4.2% | 0.00% | – |
| Q4 2018 | $0 | – | 48 | -76.0% | 0.00% | – |
| Q3 2018 | $0 | – | 200 | 0.0% | 0.00% | – |
| Q2 2018 | $0 | – | 200 | +33.3% | 0.00% | – |
| Q1 2018 | $0 | – | 150 | 0.0% | 0.00% | – |
| Q4 2017 | $0 | -100.0% | 150 | -66.7% | 0.00% | – |
| Q3 2017 | $1,000 | – | 450 | +782.4% | 0.00% | – |
| Q1 2016 | $0 | -100.0% | 51 | -90.7% | 0.00% | – |
| Q4 2015 | $2,000 | -33.3% | 551 | -16.0% | 0.00% | – |
| Q3 2015 | $3,000 | +200.0% | 656 | +184.0% | 0.00% | – |
| Q2 2015 | $1,000 | -75.0% | 231 | -78.0% | 0.00% | – |
| Q1 2015 | $4,000 | – | 1,050 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| THOMPSON DAVIS & CO., INC. | 1,800 | $8,000 | 0.01% |
| VANGUARD GROUP INC | 4,644,077 | $162,991,000 | 0.01% |
| LADENBURG THALMANN FINANCIAL SERVICES INC. | 38,888 | $158,000 | 0.00% |
| Winfield Associates, Inc. | 786 | $3,000 | 0.00% |
| Virtu KCG Holdings LLC | 11,022 | $48,000 | 0.00% |
| UBS Group AG | 182 | $0 | 0.00% |
| BLACKROCK ADVISORS LLC | 2,800 | $12,000 | 0.00% |
| US BANCORP \DE\ | 100 | $0 | 0.00% |
| AMERICAN INTERNATIONAL GROUP, INC. | 37 | $0 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 150 | $1,000 | 0.00% |